Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
Background: An increasing body of evidence shows that miR-34 family has tumor suppressive properties mediating apoptosis, cell cycle arrest and senescence. In ovarian cancer, miR34 family members were found to be under expressed. Particularly miR-34a has been revealed to be a direct transcriptional...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 February 2016
|
| In: |
BMC cancer
Year: 2016, Jahrgang: 16 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-016-2135-2 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1186/s12885-016-2135-2 Verlag, Volltext: https://doi.org/10.1186/s12885-016-2135-2 
|
| Verfasserangaben: | Gabriel Schmid, Sara Notaro, Daniel Reimer, Samira Abdel-Azim, Michaela Duggan-Peer, Jessica Holly, Heidi Fiegl, Julia Rössler, Annemarie Wiedemair, Nicole Concin, Peter Altevogt, Christian Marth and Alain Gustave Zeimet |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1587357186 | ||
| 003 | DE-627 | ||
| 005 | 20220815100957.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190207s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12885-016-2135-2 |2 doi | |
| 035 | |a (DE-627)1587357186 | ||
| 035 | |a (DE-576)517357186 | ||
| 035 | |a (DE-599)BSZ517357186 | ||
| 035 | |a (OCoLC)1341037199 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schmid, Gabriel |e VerfasserIn |0 (DE-588)1177274280 |0 (DE-627)1048648125 |0 (DE-576)517354721 |4 aut | |
| 245 | 1 | 0 | |a Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer |c Gabriel Schmid, Sara Notaro, Daniel Reimer, Samira Abdel-Azim, Michaela Duggan-Peer, Jessica Holly, Heidi Fiegl, Julia Rössler, Annemarie Wiedemair, Nicole Concin, Peter Altevogt, Christian Marth and Alain Gustave Zeimet |
| 264 | 1 | |c 15 February 2016 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.02.2019 | ||
| 520 | |a Background: An increasing body of evidence shows that miR-34 family has tumor suppressive properties mediating apoptosis, cell cycle arrest and senescence. In ovarian cancer, miR34 family members were found to be under expressed. Particularly miR-34a has been revealed to be a direct transcriptional target of p53 which is frequently mutated in epithelial ovarian carcinomas especially in high grade serous cancer. Moreover, methylation of miR-34a CpG Islands was found to down-regulate miR-34a expression. The aim of this study was to investigate the clinical relevance of mir34a as well as its promoter methylation in a subset of 133 ovarian cancers with a special focus on the p53 mutation status, the dualistic type I and type II ovarian cancer model and the different histotypes. Methods: One hundred thirty-three epithelial ovarian cancers and 8 samples of healthy ovarian surface epithelium were retrospectively analysed for miR-34a expression with quantitative real-time reverse transcription PCR (qRT-PCR). Gene-specific DNA methylation was evaluated with MethyLight technique. Results: Significantly lower miR-34a expression was found in ovarian cancers than in healthy ovarian epithelium (p = 0.002). The expression of miR-34a was found lower in type II than in type I cancers (p = 0.037), in p53 mutated as compared to p53 wild type cancers (p = 0.003) and in high grade compared to in low grade cancers (p = 0.028). In multivariate COX regression model low expressing miR-34a cancers exhibited a reduced PFS (p = 0.039) and OS (p = 0.018). In serous cancers low miR-34a levels showed a worse OS confirmed also in multivariate analysis (p = 0.022). miR-34a promoter methylation was found higher in type II cancers than in type I (p = 0.006). mir34a expression and promoter methylation showed an inverse correlation in cancer samples (p = 0.05). Conclusion: We demonstrated a clinical independent role of miR-34a in epithelial ovarian cancers. Moreover, we corroborated the correlation between miR-34a expression and its promoter methylation in a large set of ovarian cancers. The inverse association between miR-34a expression and grading, p53 mutation status and dualistic tumor type classification, together with its prognostic relevance may underline the tumor-suppressive character of miR-34a in ovarian cancer. | ||
| 700 | 1 | |a Altevogt, Peter |d 1947- |e VerfasserIn |0 (DE-588)1113206306 |0 (DE-627)867118784 |0 (DE-576)164729240 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 16(2016) Artikel-Nummer 102, 8 Seiten |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer |
| 773 | 1 | 8 | |g volume:16 |g year:2016 |g extent:8 |a Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12885-016-2135-2 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12885-016-2135-2 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190207 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1113206306 |a Altevogt, Peter |m 1113206306:Altevogt, Peter |d 60000 |d 61900 |d 50000 |e 60000PA1113206306 |e 61900PA1113206306 |e 50000PA1113206306 |k 0/60000/ |k 1/60000/61900/ |k 0/50000/ |p 11 | ||
| 999 | |a KXP-PPN1587357186 |e 3055253027 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer","title_sort":"Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Schmid, Gabriel","given":"Gabriel","family":"Schmid"},{"given":"Peter","family":"Altevogt","role":"aut","roleDisplay":"VerfasserIn","display":"Altevogt, Peter"}],"recId":"1587357186","language":["eng"],"note":["Gesehen am 07.02.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1587357186"],"doi":["10.1186/s12885-016-2135-2"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"15 February 2016"}],"name":{"displayForm":["Gabriel Schmid, Sara Notaro, Daniel Reimer, Samira Abdel-Azim, Michaela Duggan-Peer, Jessica Holly, Heidi Fiegl, Julia Rössler, Annemarie Wiedemair, Nicole Concin, Peter Altevogt, Christian Marth and Alain Gustave Zeimet"]},"relHost":[{"origin":[{"dateIssuedDisp":"2001-","dateIssuedKey":"2001","publisher":"BioMed Central ; Springer","publisherPlace":"London ; Berlin ; Heidelberg"}],"id":{"zdb":["2041352-X"],"eki":["326643710"],"issn":["1471-2407"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}],"note":["Gesehen am 22.05.20"],"disp":"Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancerBMC cancer","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"326643710","pubHistory":["1.2001 -"],"part":{"text":"16(2016) Artikel-Nummer 102, 8 Seiten","volume":"16","extent":"8","year":"2016"}}],"physDesc":[{"extent":"8 S."}]} | ||
| SRT | |a SCHMIDGABREXPRESSION1520 | ||